{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:22:17Z","timestamp":1793038937767,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cytogfr.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T22:01:29Z","timestamp":1371765689000},"page":"443-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis"],"prefix":"10.1016","volume":"24","author":[{"given":"Hong-Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2013.05.005_bib0005","doi-asserted-by":"crossref","first-page":"357412","DOI":"10.1155\/2010\/357412","article-title":"The role of apolipoprotein E in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"2010","author":"Zhang","year":"2010","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/exnr.2002.7944","article-title":"CD4 and CD8 T cells, but not B cells, are critical to the control of murine experimental autoimmune neuritis","volume":"177","author":"Zhu","year":"2002","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain\u2013Barr\u00e9 syndrome","volume":"258","author":"Lu","year":"2011","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0020","first-page":"1462","article-title":"Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux","volume":"28","author":"Guillain","year":"1916","journal-title":"Bulletins et Memoires Societe Medicale des Hopitaux de Paris"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(93)90324-R","article-title":"Severe axonal degeneration in acute Guillain\u2013Barr\u00e9 syndrome: evidence of two different mechanisms?","volume":"116","author":"Feasby","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","article-title":"Guillain\u2013Barr\u00e9 syndrome subtypes related to Campylobacter infection","volume":"82","author":"Drenthen","year":"2011","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barr\u00e9 syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Fisher","year":"1956","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp-2011-300309","article-title":"Antiganglioside antibodies are associated with axonal Guillain\u2013Barr\u00e9 syndrome: a Japanese\u2013Italian collaborative study","volume":"83","author":"Sekiguchi","year":"2012","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0065","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00687602","article-title":"Suppression of experimental allergic neuritis in rats by prior immunization with nerve in saline","volume":"18","author":"Lehrich","year":"1971","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(90)90098-8","article-title":"Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53\u201378 amino acid sequence of the myelin P2 protein","volume":"30","author":"Rostami","year":"1990","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-4547(20001201)62:5<717::AID-JNR11>3.0.CO;2-P","article-title":"P0 protein peptide 180\u2013199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL\/6 mice","volume":"62","author":"Zou","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0960-8966(01)00302-9","article-title":"Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models","volume":"12","author":"Maurer","year":"2002","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00688630","article-title":"Blood\u2013nerve barrier studies in experimental allergic neuritis","volume":"68","author":"Hahn","year":"1985","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/WNL.53.1.20","article-title":"Matrix metalloproteinases in inflammatory demyelination: targets for treatment","volume":"53","author":"Kieseier","year":"1999","journal-title":"Neurology"},{"issue":"27 Suppl.","key":"10.1016\/j.cytogfr.2013.05.005_bib0100","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain\u2013Barr\u00e9 syndrome","author":"Hartung","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","article-title":"M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells","volume":"187","author":"Heusinkveld","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/glia.20498","article-title":"Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells","volume":"55","author":"Duan","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2990.2002.00421.x","article-title":"Accumulation of immunoglobulin across the \u2018blood\u2013nerve barrier\u2019 in spinal roots in adoptive transfer experimental autoimmune neuritis","volume":"28","author":"Hadden","year":"2002","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","article-title":"IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease","volume":"32","author":"Zepp","year":"2011","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s004010050801","article-title":"Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis","volume":"95","author":"Vriesendorp","year":"1998","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0135","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/ni0606-539","article-title":"Origins of the T(H)1-T(H)2 model: a personal perspective","volume":"7","author":"Coffman","year":"2006","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2893.2007.00908.x","article-title":"Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease","volume":"15","author":"Gigi","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0150","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0105-2896.2004.00209.x","article-title":"Signaling pathways in Th2 development","volume":"202","author":"Mowen","year":"2004","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nri705","article-title":"T(H)1 and T(H)2 cells: a historical perspective","volume":"2","author":"Liew","year":"2002","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0170","doi-asserted-by":"crossref","first-page":"949072","DOI":"10.1155\/2011\/949072","article-title":"Cross-talk between apolipoprotein E and cytokines","volume":"2011","author":"Zhang","year":"2011","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain\u2013Barr\u00e9 syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneurol.2011.47","article-title":"Cytokines in Guillain\u2013Barr\u00e9 syndrome: a lesson in time","volume":"68","author":"Lambracht-Washington","year":"2011","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clinical Immunology and Immunopathology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain\u2013Barr\u00e9 syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1750-3639.2002.tb00459.x","article-title":"The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis","volume":"12","author":"Bao","year":"2002","journal-title":"Brain Pathology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jaut.1998.0259","article-title":"Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination","volume":"12","author":"Deretzi","year":"1999","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clin.1997.4331","article-title":"IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses","volume":"83","author":"Bai","year":"1997","journal-title":"Clinical Immunology and Immunopathology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ana.410280113","article-title":"Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis","volume":"28","author":"Schmidt","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-510X(93)90134-K","article-title":"Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis","volume":"119","author":"Jung","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0230","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.0901088","article-title":"Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects","volume":"183","author":"Zhang","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0235","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.165.11.6107","article-title":"Microbial lipopeptides induce the production of IL-17 in Th cells","volume":"165","author":"Infante-Duarte","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0240","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","article-title":"Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus","volume":"10","author":"Doreau","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0245","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0260","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3349\/ymj.2010.51.4.484","article-title":"Transcriptional regulation of T helper 17 cell differentiation","volume":"51","author":"Hwang","year":"2010","journal-title":"Yonsei Medical Journal"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0270","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"Interleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0275","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0285","doi-asserted-by":"crossref","first-page":"260473","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain\u2013Barr\u00e9 syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0295","first-page":"55S","article-title":"T regulatory cells in allergy","volume":"24","author":"Braga","year":"2011","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0300","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.coi.2006.06.003","article-title":"Healthy immune response to allergens: T regulatory cells and more","volume":"18","author":"Akdis","year":"2006","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0305","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0315","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+ CD25\u2212 naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0320","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","article-title":"Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barr\u00e9 syndrome patients compared to controls","volume":"15","author":"Harness","year":"2008","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0325","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","article-title":"Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"192","author":"Chi","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0330","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20082113","article-title":"A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy","volume":"206","author":"Louvet","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cellimm.2011.08.015","article-title":"Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1\/Th17 cytokines and up-regulated T regulatory cells","volume":"271","author":"Li","year":"2011","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0345","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1359-6101(97)00009-9","article-title":"The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor","volume":"8","author":"Pestka","year":"1997","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-5728(98)00053-8","article-title":"Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha\/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage","volume":"87","author":"Hohnoki","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0360","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/clin.1998.4573","article-title":"Recovery from Guillain\u2013Barr\u00e9 syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma","volume":"88","author":"Elkarim","year":"1998","journal-title":"Clinical Immunology and Immunopathology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0370","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.410270306","article-title":"The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system","volume":"27","author":"Hartung","year":"1990","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0375","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1006\/exnr.2001.7662","article-title":"Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice","volume":"169","author":"Zhu","year":"2001","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0463.2003.apm1111204.x","article-title":"Elevated number of cells secreting transforming growth factor beta in Guillain\u2013Barr\u00e9 syndrome","volume":"111","author":"Dahle","year":"2003","journal-title":"Acta Pathologica, Microbiologica, et Immunologica Scandinavica"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(00)00388-X","article-title":"IL-10 and IFN-gamma in Guillain\u2013Barr\u00e9 syndrome. Network Members of the Swedish Epidemiological Study Group","volume":"112","author":"Press","year":"2001","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0390","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.192.1.123","article-title":"Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis","volume":"192","author":"Chu","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0395","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0400","first-page":"70","article-title":"Tumor necrosis factor-alpha in experimental autoimmune neuritis","volume":"5","author":"Mao","year":"2010","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0405","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2012.05057.x","article-title":"Systematic review: antibodies and anti-TNF-alpha levels in inflammatory bowel disease","author":"Chaparro","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.193.4.427","article-title":"Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination","volume":"193","author":"Kassiotis","year":"2001","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0415","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","article-title":"Association of tumor necrosis factor polymorphisms with Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Zhang","year":"2007","journal-title":"European Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0425","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2011.12.003","article-title":"The effect of TNF-alpha, FcgammaR and CD1 polymorphisms on Guillain\u2013Barr\u00e9 syndrome risk: evidences from a meta-analysis","volume":"243","author":"Wu","year":"2012","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0404.2003.00179.x","article-title":"Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain\u2013Barre syndrome","volume":"109","author":"Radhakrishnan","year":"2004","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0435","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","article-title":"The role of IL-12 and TNF-alpha in AIDP and AMAN","volume":"15","author":"Deng","year":"2008","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0440","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410330606","article-title":"Elevated serum levels of tumor necrosis factor-alpha in Guillain\u2013Barr\u00e9 syndrome","volume":"33","author":"Sharief","year":"1993","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004010050765","article-title":"Tumor necrosis factor-alpha in peripheral nerve lesions","volume":"95","author":"Oka","year":"1998","journal-title":"Acta Neuropathologica"},{"issue":"Pt 4","key":"10.1016\/j.cytogfr.2013.05.005_bib0450","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","article-title":"Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor","volume":"118","author":"Redford","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0455","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0923-2494(92)80040-R","article-title":"Nerve lesions induced by macrophage activation","volume":"143","author":"Said","year":"1992","journal-title":"Research in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0969-9961(02)00007-4","article-title":"Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis","volume":"12","author":"Bao","year":"2003","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0465","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0028-3908(99)00144-6","article-title":"Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats","volume":"39","author":"Zou","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0470","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2249.1999.00768.x","article-title":"Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses","volume":"115","author":"Zhu","year":"1999","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0475","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","article-title":"The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death","volume":"76","author":"Smith","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.2000.1706","article-title":"Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis","volume":"205","author":"Suvannavejh","year":"2000","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2007.02.004","article-title":"Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice","volume":"186","author":"Lu","year":"2007","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0490","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2009.12.045","article-title":"TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice","volume":"470","author":"Mao","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0495","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.berh.2011.10.004","article-title":"Anti-TNF therapy","volume":"25","author":"Thalayasingam","year":"2011","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0500","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0505","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain\u2013Barr\u00e9 and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0510","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/mus.21367","article-title":"Peripheral neuropathy in two patients with psoriasis in treatment with infliximab","volume":"40","author":"Eguren","year":"2009","journal-title":"Muscle and Nerve"},{"issue":"Suppl. 3","key":"10.1016\/j.cytogfr.2013.05.005_bib0515","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1186\/ar557","article-title":"Studies of T-cell activation in chronic inflammation","volume":"4","author":"Cope","year":"2002","journal-title":"Arthritis Research"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0520","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","volume":"205","author":"Notley","year":"2008","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0525","first-page":"2010","article-title":"Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27","author":"Xu","year":"2010","journal-title":"Clinical and Developmental Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0530","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(03)00043-1","article-title":"The biology of IL-12: coordinating innate and adaptive immune responses","volume":"14","author":"Watford","year":"2003","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0535","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0540","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3083.2000.00636.x","article-title":"Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats","volume":"51","author":"Pelidou","year":"2000","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0545","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0550","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0555","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1189\/jlb.0602326","article-title":"A unique role for IL-23 in promoting cellular immunity","volume":"73","author":"Lankford","year":"2003","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri2225","article-title":"How microorganisms tip the balance between interleukin-12 family members","volume":"8","author":"Goriely","year":"2008","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/dnp.2006.19.2.977443","article-title":"Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis","volume":"19","author":"Touil","year":"2006","journal-title":"Drug News & Perspectives"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0570","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0575","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneur.63.6.858","article-title":"Interleukin 23 in acute inflammatory demyelination of the peripheral nerve","volume":"63","author":"Hu","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0580","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0585","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0590","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0595","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.2042fta","article-title":"Th1\/Th2 cross-regulation and the discovery of IL-10","volume":"204","author":"Bashyam","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0600","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1096\/fj.99-0874fje","article-title":"A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding","volume":"14","author":"Akdis","year":"2000","journal-title":"FASEB Journal"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0605","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaci.2007.04.004","article-title":"IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1","volume":"120","author":"Taylor","year":"2007","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0610","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","article-title":"Interleukin-10 promoter polymorphisms in patients with Guillain\u2013Barr\u00e9 syndrome","volume":"139","author":"Myhr","year":"2003","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0615","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","article-title":"Immune responses to myelin proteins in Guillain\u2013Barr\u00e9 syndrome","volume":"79","author":"Makowska","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0620","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","article-title":"Non-T(H)1 cytokines are augmented systematically early in Guillain\u2013Barr\u00e9 syndrome","volume":"58","author":"Press","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0625","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1529-8027.2007.00148.x","article-title":"Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repair","volume":"12","author":"Atkins","year":"2007","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are T(H)2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0635","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","article-title":"The IL-4 receptor: signaling mechanisms and biologic functions","volume":"17","author":"Nelms","year":"1999","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0640","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/intimm\/dxh050","article-title":"IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms","volume":"16","author":"Wurtz","year":"2004","journal-title":"International Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0645","first-page":"2943","article-title":"Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells","volume":"181","author":"Le Gros","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0650","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0655","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.166.12.7276","article-title":"Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion","volume":"166","author":"Zhu","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0660","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","article-title":"Stat6 is required for mediating responses to IL-4 and for development of Th2 cells","volume":"4","author":"Kaplan","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0665","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-510X(97)00178-0","article-title":"T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain\u2013Barr\u00e9 syndrome","volume":"153","author":"Dahle","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0670","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1468-1331.1996.tb00428.x","article-title":"Dynamics of mRNA expression of interferon-gamma, interleukin 4 and transforming growth factor beta1 in sciatic nerves and lymphoid organs in experimental allergic neuritis","volume":"3","author":"Zhu","year":"1996","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0675","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08916930008994078","article-title":"Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system","volume":"32","author":"Abbas","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0680","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2011.12.008","article-title":"Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis","volume":"243","author":"Chen","year":"2012","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0685","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cyto.2011.08.036","article-title":"TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation","volume":"56","author":"Olsen","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0690","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0695","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0700","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0705","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0710","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","article-title":"FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis","volume":"35","author":"Zhang","year":"2009","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0715","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2009.09.010","article-title":"AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis","volume":"216","author":"Zhang","year":"2009","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0720","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/exnr.2000.7357","article-title":"Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role","volume":"163","author":"Pelidou","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0725","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood.V56.6.947.947","article-title":"The nature and action of granulocyte-macrophage colony stimulating factors","volume":"56","author":"Burgess","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0730","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0735","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1615\/CritRevImmunol.v25.i5.50","article-title":"Functions of granulocyte-macrophage colony-stimulating factor","volume":"25","author":"Fleetwood","year":"2005","journal-title":"Critical Reviews in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0740","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0745","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1471-4906(02)02260-3","article-title":"GM-CSF in inflammation and autoimmunity","volume":"23","author":"Hamilton","year":"2002","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0750","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.194.7.873","article-title":"Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis","volume":"194","author":"McQualter","year":"2001","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0755","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4049\/jimmunol.178.1.39","article-title":"GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis","volume":"178","author":"Ponomarev","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0760","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/ar318","article-title":"Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease","volume":"3","author":"Cook","year":"2001","journal-title":"Arthritis Research"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0765","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ana.410070413","article-title":"The acute sensory neuronopathy syndrome: a distinct clinical entity","volume":"7","author":"Sterman","year":"1980","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0770","first-page":"355","article-title":"Pure pan-dysautonomia with recovery","volume":"94","author":"Young","year":"1969","journal-title":"Transactions of the American Neurological Association"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0775","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1212\/WNL.44.9.1675","article-title":"Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients","volume":"44","author":"Suarez","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0780","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2013.05.005_bib0785","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archneur.1986.00520110044012","article-title":"Unusual clinical variants and signs in Guillain\u2013Barr\u00e9 syndrome","volume":"43","author":"Ropper","year":"1986","journal-title":"Archives of Neurology"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:54:07Z","timestamp":1761216847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610113000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":157,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1359610113000531"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.05.005","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}